Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Stelara
Pharma
J&J charts speedy launch of new psoriasis pill Icotyde
Protagonist Therapeutics-partnered Icotyde has the potential to become one of Johnson & Johnson's "largest products ever," CEO Joaquin Duato said.
Zoey Becker
Apr 14, 2026 11:43am
Inside the turning tides of the US biosimilar market
Jan 8, 2026 9:00am
J&J logs strong innovative drug sales despite Stelara's decline
Jul 16, 2025 11:19am
J&J lifts 2025 sales guidance despite looming tariff threat
Apr 15, 2025 11:55am
A closer look at pharma’s top patent losses in 2025
Mar 21, 2025 9:00am
J&J's Tremfya picks up key FDA nod in Crohn's disease
Mar 20, 2025 7:56pm
